logo-loader

ImmunoPrecise Antibodies Ltd

Receive alerts
Market:
TSX-V
Market Cap:
$31.96 m
Price
0.47 CAD
Change
-7.84%
52 weeks high
0.94
52 weeks low
0.45

In brief

ImmunoPrecise is a full-service, therapeutic antibody discovery company focused on the next generation of antibody discovery, to deliver the most therapeutically-relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials.

Deep dive We explore the investor case for growth companies

Snapshot

The biotech company is the world’s only single source contract resource organization to offer the full complement of antibody discovery platforms